Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 712

The DOI matches its Crossref record.

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

Ormiston, John A, Serruys, Patrick W, Regar, Evelyn, Dudek, Dariusz, Thuesen, Leif, Webster, Mark WI, Onuma, Yoshinobu, Garcia-Garcia, Hector M, McGreevy, Robert, Veldhof, Susan·2008·The Lancet
DOI 10.1016/s0140-6736(08)60415-8
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(08)60415-8

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 27

  1. Mintz, 1996, Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study, Circulation, 94, 35, 10.1161/01.CIR.94.1.35 · DOI · Paper page
  2. Serruys, 2006, Coronary-artery stents, N Engl J Med, 354, 483, 10.1056/NEJMra051091 · DOI · Paper page
  3. Kotani, 2006, Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings, J Am Coll Cardiol, 47, 2108, 10.1016/j.jacc.2005.11.092 · doi:10.1016/j.jacc.2005.11.092
  4. Finn, 2007, Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization, Circulation, 115, 2435, 10.1161/CIRCULATIONAHA.107.693739 · DOI · Paper page
  5. Daemen, 2007, Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study, Lancet, 369, 667, 10.1016/S0140-6736(07)60314-6 · DOI · Paper page
  6. Tamai, 2000, Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans, Circulation, 102, 399, 10.1161/01.CIR.102.4.399 · DOI · Paper page
  7. Erbel, 2007, Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial, Lancet, 369, 1869, 10.1016/S0140-6736(07)60853-8 · DOI · Paper page
  8. Cutlip, 2007, Clinical end points in coronary stent trials: a case for standardized definitions, Circulation, 115, 2344, 10.1161/CIRCULATIONAHA.106.685313 · DOI · Paper page
  9. Bruining, 1998, ECG-gated versus nongated three-dimensional intracoronary ultrasound analysis: implications for volumetric measurements, Cathet Cardiovasc Diagn, 43, 254, 10.1002/(SICI)1097-0304(199803)43:3<254::AID-CCD3>3.0.CO;2-8 · doi:10.1002/(sici)1097-0304(199803)43:3<254::aid-ccd3>3.0.co;2-8
  10. von Birgelen, 1997, ECG-gated three-dimensional intravascular ultrasound: feasibility and reproducibility of the automated analysis of coronary lumen and atherosclerotic plaque dimensions in humans, Circulation, 96, 2944, 10.1161/01.CIR.96.9.2944 · DOI
  11. Nair, 2002, Coronary plaque classification with intravascular ultrasound radiofrequency data analysis, Circulation, 106, 2200, 10.1161/01.CIR.0000035654.18341.5E · DOI
  12. Nair, 2001, Assessing spectral algorithms to predict atherosclerotic plaque composition with normalized and raw intravascular ultrasound data, Ultrasound Med Biol, 27, 1319, 10.1016/S0301-5629(01)00436-7 · doi:10.1016/s0301-5629(01)00436-7
  13. Nair, 2007, Automated coronary plaque characterisation with intravascular ultrasound backscatter: ex vivo validation, EuroInterv, 3, 113
  14. Tanigawa, 2007, Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition, EuroInterv, 3, 128
  15. Serruys, 2005, A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: the SPIRIT first trial, EuroInterv, 1, 58
  16. Serruys, 2006, A randomized comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial, EuroInterv, 2, 286
  17. Sousa, 2001, Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up, Circulation, 104, 2007, 10.1161/hc4201.098056 · DOI · Paper page
  18. Rensing, 2001, Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up, Eur Heart J, 22, 2125, 10.1053/euhj.2001.2892 · DOI · Paper page
  19. Silber, 2005, Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology, Eur Heart J, 26, 804, 10.1093/eurheartj/ehi138 · DOI · Paper page
  20. Smith, 2006, Circulation, 113, 156, 10.1161/CIRCULATIONAHA.105.170815 · DOI · Paper page
  21. Tanabe, 2005, Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial, Circulation, 111, 900, 10.1161/01.CIR.0000155607.54922.16 · doi:10.1161/01.cir.0000155607.54922.16
  22. Stone, 2004, A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease, N Engl J Med, 350, 221, 10.1056/NEJMoa032441 · DOI · Paper page
  23. Grube, 2004, Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer, Circulation, 109, 2168, 10.1161/01.CIR.0000128850.84227.FD · DOI · Paper page
  24. Costa, 2005, Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial), Am J Cardiol, 95, 113, 10.1016/j.amjcard.2004.08.074 · doi:10.1016/j.amjcard.2004.08.074
  25. Meredith, 2005, First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial, EuroInterv, 1, 157
  26. Fajadet, 2006, Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial, Circulation, 114, 798, 10.1161/CIRCULATIONAHA.105.591206 · DOI · Paper page
  27. Tanimoto, 2007, Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials, Catheter Cardiovasc Interv, 70, 515, 10.1002/ccd.21136 · DOI

Cited by

See all 712

Metadata

Authors
Ormiston, J. A., Serruys, P. W., Regar, E., Dudek, D., Thuesen, L., Webster, M. W., Onuma, Y., Garcia-Garcia, H. M., McGreevy, R., & Veldhof, S.
Venue
The Lancet
Publisher
Elsevier BV
Published
2008-03
Volume
371
Issue
9616
Pages
899-907
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
DOI
10.1016/s0140-6736(08)60415-8
OpenAlex
W2160631086
Cited by
712
References
0
FWCI
61.42
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. https://app.cochat.ai/papers/10.1016/s0140-6736(08)60415-8
The paper
Ormiston, J. A., Serruys, P. W., Regar, E., Dudek, D., Thuesen, L., Webster, M. W., Onuma, Y., Garcia-Garcia, H. M., McGreevy, R., & Veldhof, S. (2008). A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. The Lancet. https://doi.org/10.1016/s0140-6736(08)60415-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.